Beta-agarase mutant with improved thermal stability and construction method thereof
By mutation of S277P or S294G sites on the amino acid sequence of β-agazase Y3R1, the problem of insufficient thermal stability of β-agazase is solved, and the enzyme activity and thermal stability is significantly improved. It is suitable for industrial application.
Patent Information
- Application Number
- CN202411453194.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-17
- Publication Date
- 2024-11-26
AI Technical Summary
The thermal stability of the existing β-agarase is insufficient, making it difficult to meet the needs of industrial production, and the thermal stability of β-agarase in related technologies still needs to be improved.
By mutations on the amino acid sequence of β-agarase Y3R1, especially mutations at S277P or S294G sites, their thermal stability and enzyme activity were improved, and their thermal stability and enzyme activity were screened using kinetic simulation, PoPMuSiC, HoTMuSiC and I-Mutant 2.0 and other software Mutation sites and mutants were constructed by PCR and recombinant techniques.
The enzyme activity of the mutants S277P and S294G increased by 59.5% and 21.6%, and the thermal stability increased by 67.0% and 70.1% respectively after treatment at 80°C, which significantly improved the thermal stability and vitality of the enzyme.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bioengineering, and in particular relates to a beta-agarase mutant with improved thermal stability and a construction method thereof. Background Art
[0002] β-Agarase plays an important role in the enzymatic degradation of agar and is used in the preparation of agar oligosaccharides, the preparation of seaweed protoplasts, and the extraction of bioactive substances from seaweed. However, the thermal stability of most natural agarases is not enough to meet the needs of industrial production, so it is necessary to modify their proteins. β-Agarase YM01-3 from Streptomyces agarophilus has high enzyme activity, but its thermal stability is poor.
[0003] With the rapid development of structural biology, bioinformatics and computer technology, protein computational design has become a reliable means to modify protein performance. By using computer methods to determine the mutation site, β-agarase with great industrial application potential can be obtained. However, the thermal stability of β-agarase in related technologies needs to be improved. Summary of the invention
[0004] The present invention aims to solve one of the technical problems in the above-mentioned technology at least to a certain extent. To this end, the present invention provides a β-agarase mutant with improved thermal stability and a construction method thereof, wherein the thermal stability and enzyme activity of the mutant are improved.
[0005] To this end, in the first aspect of the present invention, a β-agarase mutant with improved thermal stability is provided, wherein the mutant is mutated on the amino acid sequence of β-agarase Y3R1 shown in SEQ ID NO: 1, and the mutation site is S277P or S294G.
[0006] According to a β-agarase mutant with improved thermal stability of the present invention, the β-agarase mutant is obtained by mutating the S277P site of the β-agarase Y3R1 containing 313 amino acids whose amino acid sequence is shown in SEQ ID NO: 1, or mutating the S294G site; so that the thermal stability and enzyme activity of the mutant are improved; compared with the wild-type β-agarase Y3R1, the enzyme activities of the mutant S277P and the mutant S294G are increased by 59.5% and 21.6%; after being treated at 80° C. for 1 hour, the thermal stability of the mutant S277P and the mutant S294G is increased by 67.0% and 70.1%, respectively.
[0007] Optionally, the amino acid sequence of the mutant is shown as SEQ ID NO: 2, or as shown as SEQ ID NO: 3.
[0008] In the second aspect of the present invention, a gene encoding the above-mentioned β-agarase mutant is provided.
[0009] In the third aspect of the present invention, a construct is provided, which comprises a gene encoding the above-mentioned β-agarase mutant.
[0010] In a fourth aspect of the present invention, a recombinant cell expressing the above-mentioned β-agarase mutant, or containing the above-mentioned gene, or containing the above-mentioned construct is provided.
[0011] In a fifth aspect of the present invention, a method for constructing the above-mentioned β-agarase mutant is provided, which comprises the following steps: (1) Using four online softwares, namely kinetic simulation, PoPMuSiC, HoTMuSiC and I-Mutant 2.0, we predicted mutants with improved thermal stability. The screening conditions were set as ΔΔG<–0.3, RMSF≥0.4, DDG<0 and ΔTm>0.5, and seven single-point mutation sites were screened out. (2) designing site-directed mutagenesis primers, and performing site-directed mutagenesis on the gene of β-agarase Y3R1 whose amino acid sequence is shown in SEQ ID NO: 1 by PCR to obtain a recombinant vector containing the gene sequence of the β-agarase mutant; (3) Transform the mutated recombinant vector into Escherichia coli E. coli In BL21(DE3), induced expression and purification were performed to obtain 7 single-point mutation β-agarase mutants; (4) The enzymatic properties of seven single-point mutation β-agarase mutants were analyzed, and the β-agarase mutants S277P and S294G with co-evolved enzyme activity and thermal stability were screened out.
[0012] Optionally, the sites of the seven single point mutations are K82L, K82P, S277P, A34F, A34Y, A34W, and S294G.
[0013] Furthermore, the amplification primer sequences for the mutation site K82L are SEQ ID NO: 6 and SEQ ID NO: 7; The amplification primer sequences for the mutation site K82P are SEQ ID NO: 8 and SEQ ID NO: 9; The amplification primer sequences for the mutation site S277P are SEQ ID NO: 10 and SEQ ID NO: 11; The amplification primer sequences for mutation site A34F are SEQ ID NO: 12 and SEQ ID NO: 13; The amplification primer sequences for mutation site A34Y are SEQ ID NO: 14 and SEQ ID NO: 15; The amplification primer sequences for mutation site A34W are SEQ ID NO: 16 and SEQ ID NO: 17; The sequences of primers for amplifying the mutation site S294G are SEQ ID NO: 18 and SEQ ID NO: 19.
[0014] In the sixth aspect of the present invention, there is provided the use of the above-mentioned β-agarase mutant, or the above-mentioned encoding gene, or the above-mentioned construct, or the above-mentioned recombinant cell in degrading agar or preparing agar oligosaccharides.
[0015] Additional aspects and advantages of the present invention will be given in part in the following description and in part will be obvious from the following description, or will be learned through practice of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 This is an agarose gel electrophoresis analysis of the β-agarase gene according to an embodiment of the present invention, wherein M: Marker; 1-3: Y3R1 engineering strain; 4-6: YM01-3 engineering strain; Figure 2 SDS-PAGE analysis of β-agarase Y3R1 and its mutants according to the embodiments of the present invention; Figure 3 is the enzyme activity of β-agarase Y3R1 and its mutants according to the examples of the present invention; Figure 4 The thermal stability of β-agarase Y3R1 and its mutants according to the embodiments of the present invention; Figure 5 The tertiary structure analysis of β-agarase Y3R1 and its mutants S277P and S294G according to the embodiments of the present invention; Figure 6 Molecular docking (AB) and hydrophobic interaction (C) between S277P and neoagarotetrose according to an embodiment of the present invention; Figure 7 Molecular docking (AB) and hydrophobic interaction (C) between S294G and neoagarotetrose according to an embodiment of the present invention; Figure 8 is the Rg value of β-agarase Y3R1 and its mutants S277P and S294G at 338 K according to an embodiment of the present invention; Fig. 9 is the RMSD value of β-agarase Y3R1 and its mutants S277P and S294G at 338 K according to the embodiments of the present invention; Fig.10is the RMSF value of β-agarase Y3R1 and its mutants S277P and S294G at 338 K according to the examples of the present invention; Fig.11 SASA values of β-agarase Y3R1 and its mutants S277P and S294G at 338 K according to an embodiment of the present invention; Fig.12 LC-MS analysis of the S277P enzymatic hydrolysis product according to an embodiment of the present invention; Fig.13 LC-MS analysis of the S294G enzymatic hydrolysis product according to an embodiment of the present invention. DETAILED DESCRIPTION
[0017] Embodiments of the present invention are described in detail below, examples of which are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the present invention, and should not be construed as limiting the present invention.
[0018] The disclosure below provides many different embodiments or examples to realize different implementations of the present invention. In order to simplify the disclosure of the present invention, specific embodiments or examples are described below. Of course, they are only examples, and the purpose is not to limit the present invention. In addition, the examples of various specific processes and materials provided by the present invention, those of ordinary skill in the art can be aware of the applicability of other processes and / or the use of other materials. Unless otherwise stated, the implementation of the present invention will adopt the traditional techniques in the fields of chemistry, molecular biology, etc. within the capabilities of those skilled in the art. In addition, unless otherwise stated, in this article, nucleic acids are written from left to right in the direction of 5' to 3', and amino acid sequences are written from left to right in the direction of amino terminal to carboxyl terminal.
[0019] In the following examples, the online servers and software used are shown in Table 1.
[0020] Table 1 Online servers and software
[0021] In the following examples, YM01-3 has a catalytic N-terminal domain (GH) and an R-terminal domain of unknown function (subdivided into R1 and R2 domains), and YM01-3 has 7 α-helices and 30 β-pleated sheets, numbered α1–α7 (Table 13) and β1–β30 (Table 14), respectively.
[0022] Table 13 Amino acid numbering of the α-helical region of agarase YM01-3
[0023] Table 14 Amino acid numbering of the β-folded region of agarase YM01-3
[0024] The present invention is described below by means of illustrative specific examples, which are not intended to limit the scope of the present invention in any way. It is particularly noted that the reagents used in the present invention are commercially available unless otherwise specified.
[0025] Example 1 Construction of β-agarase Y3R1 gene recombinant strain (1) Primer design. Using the recombinant plasmid pET-28a (+) / YM01-3 containing the wild-type enzyme gene fragment (GenBank accession number: No. KF413621.1) as the template, restriction sites were added at the 5' and 3' ends respectively. Bam HI and XOt I. Design primers on the primer design website (https: / / crm.vazyme.com / cetool / simple.html) and construct β-agarase Y3R1 according to the CD-Search analysis on the NCBI website. The primers for β-agarase Y3R1 are shown in Table 2.
[0026] Table 2 β-Agarase Y3R1 Primers
[0027] (2) PCR amplification of β-agarase Y3R1 gene. The recombinant plasmid pET-28a (+) / YM01-3 containing the wild-type enzyme gene fragment (GenBank accession number No. KF413621.1) was used as a template to amplify the target Y3R1 gene using PCR technology. The amplification reaction system and reaction conditions are shown below, where the specific upstream and downstream primers were purchased from Borui Biotechnology Co., Ltd. Plasmid extraction was performed according to the instructions of the bacterial plasmid mini-extraction kit of TianGen.
[0028] Table 3 Amplification reaction system
[0029] Table 4 Amplification reaction conditions
[0030] Refer to the instructions of TianGen's DNA purification kit to recover the target gene fragment and store it at -20 ºC.
[0031] (3) Double restriction enzyme digestion reaction of target gene and expression plasmid. The reaction conditions are as follows: mix the reagents, centrifuge briefly, and react at 37 ºC for 1 h. After the double restriction enzyme digestion reaction, use a DNA purification kit to recover the DNA fragments, and use an ELISA reader to measure the concentration of the recovered products. The reaction system is shown in Table 5.
[0032] Table 5 Double enzyme digestion reaction system
[0033] (4) Ligation reaction. The reaction conditions are as follows: after the reagents are mixed, centrifuge briefly and react at 16°C for 40 min; after the ligation reaction, use a DNA purification kit to recover the DNA fragments, then use 1% agarose gel electrophoresis to detect the target gene bands, and use an enzyme reader to determine the concentration of the recovered product. The reaction system is shown in Table 6.
[0034] Table 6 Ligation reaction system
[0035] (5) Conversion reaction. Thaw on ice E. coli DH5α or E. coli BL21 (DE3) competent cells. Add 20 μL of the ligation product to 100 μL of competent cells and place on ice for 30 min. Heat shock in a water bath at 42 °C for 90 sec, and immediately place on ice to cool for 2-3 min. Add 900 μL of LB liquid medium (without kanamycin) and shake at 37 °C for 60 min. Centrifuge at 3000-3500 rpm for 3 min. Remove 800 μL of supernatant and resuspend the cells with a pipette. Use a sterile spreader to spread the bacterial solution onto an LB solid medium plate (containing 50 μg / mL of kanamycin sulfate). Place the plate in a 37 °C incubator and invert for 12-16 h.
[0036] (6) Identification of positive transformants. Pick a single colony from the overnight culture and place it in 10 mL LB liquid medium (containing kanamycin sulfate) for expansion culture for 12-16 h. Perform PCR on the bacterial solution. The PCR reaction system and reaction conditions are shown in Tables 7 and 8. Use 1% agarose gel electrophoresis to detect the size of the PCR product. The results are as follows: Figure 1 As shown, the gene fragment size of β-agarase Y3R1 is between 1000 bp and 750 bp, which is consistent with the theoretical value of 939 bp. The bacterial solution was sent to Xiamen Borui Biotechnology Co., Ltd. for sequencing identification, and the sequencing results were analyzed using DNAMAN 9.0 software. The sequencing results showed that the target sequence of the inserted gene was consistent with the theoretical sequence.
[0037] Table 7 Amplification reaction system
[0038] Table 8 Amplification reaction conditions
[0039] Example 2 Selection of β-agarase mutation sites Four servers (PoPMuSiC, HoTMuSiC, I-mutant 2.0 and molecular dynamics simulation) were used to predict and screen single mutants with improved thermal stability of β-agarase. The screening conditions were set as ΔΔG<–0.3, RMSF≥0.4, DDG<0 and ΔTm>0.5. The PoPMuSiC online server evaluates the unfolding free energy (ΔΔG) of amino acids. The smaller the ΔΔG, the lower the energy of the amino acid residue after mutation, which is conducive to the structural stability of the protein. HoTMuSiC is a tool for predicting the effect of point mutations on the melting temperature of proteins. It screens all possible amino acid substitutions in the target protein to achieve protein optimization and obtain a more heat-resistant protease. The higher the melting temperature ΔTm of the enzyme after mutation, the better the protein is at adapting to high temperature environments. The RMSF of dynamic simulation is used to describe the flexibility of protein structure. Selecting amino acids with larger RMSF as mutation sites is conducive to improving the rigidity of the protein. Based on the mutants screened above, they were substituted into I-mutant 2.0 for verification to obtain the final results. I-mutant2.0 is used to calculate the stability changes of mutants before and after mutation. DDG>0 means that the mutation will cause protein instability, and DDG<0 means that the protein structure is more stable after mutation.
[0040] Some of the screening results of the four servers (PoPMuSiC, HoTMuSiC, dynamic simulation and I-mutant 2.0) are shown in Table 9. Through analysis, it was found that there were 3 mutants (K82L, K82P and S277P) predicted well by all four servers, and 4 points (A34F, A34Y, A34W and S294G) predicted well by all three servers. Therefore, these 7 single mutants were selected for further experimental analysis.
[0041] Table 9 Analysis results of different online servers
[0042] Example 3 Construction of mutant β-agarase recombinant strain The recombinant plasmid containing β-agarase Y3R1 gene (pET-28a-aga) E. coliAfter culturing the DH5α strain (obtained in Example 1) in LB liquid medium (containing 50 μg / mL kanamycin), the plasmid was extracted according to the instructions of the bacterial plasmid extraction kit of TianGen. Referring to the instructions of the Mut ExpressⅡ Fast Mutagenesis Kit V2 site-directed mutagenesis kit, the primer sequences designed according to the selected amino acid sites to be mutated (obtained in Example 2) are shown in Table 10.
[0043] Table 10 Mutation Primers
[0044] Note: Lowercase letters indicate mutation sites.
[0045] The mutant enzyme gene was amplified by PCR reaction using the β-agarase Y3R1 recombinant plasmid as a template. The PCR reaction system is shown in Table 10. The PCR reaction conditions are: pre-denaturation at 95°C for 30s; denaturation at 95°C for 15s; annealing at 62°C for 15s; extension at 72°C for 60s; denaturation, annealing, and extension as one cycle, 30 cycles; complete extension at 72°C for 5 min, and storage at 4°C.
[0046] Table 11 PCR reaction system
[0047] Digestion reaction: After the PCR reaction is completed, since the amplified product contains the original plasmid template, in order to prevent the formation of false positive transformants, 1 μL of Dpn Ⅰ digestion to remove the methylated plasmid template.
[0048] Recombination reaction: remove 4 μL of the final product, add 4 μL of 5×CE Ⅱ Buffer, 2 μL of Exnase Ⅱ, and 10 μL of sterile water, centrifuge briefly in a small centrifuge, mix well, react at 37°C for 30 min, and then store at 4°C.
[0049] Transformation reaction: Thaw on ice E. coli DH5α or E. coliBL21 (DE3) competent cells. Add 20 μL of the ligation product to 100 μL of competent cells and place on ice for 30 min. Heat shock in a water bath at 42 °C for 90 sec, and immediately place on ice to cool for 2-3 min. Add 900 μL of LB liquid medium (without kanamycin) and shake at 37 °C for 60 min. Centrifuge at 3000-3500 rpm for 3 min. Remove 800 μL of supernatant and resuspend the cells with a pipette. Use a sterile spreader to spread the bacterial solution onto an LB solid medium plate (containing 50 μg / mL of kanamycin sulfate). Place the plate in a 37 °C incubator and invert for 12-16 h.
[0050] Identification of positive transformants: Pick a single colony from overnight culture and place it in 10 mL LB liquid medium (containing kanamycin sulfate) for expansion culture for 12-16 hours. Perform PCR on the bacterial solution. The PCR reaction system and reaction conditions are shown in Tables 7 and 8 above.
[0051] Example 4 Inducible expression and purification of mutant β-agarase Inducible expression of mutant β-agarase: The recombinant plasmid containing mutant β-agarase (obtained in Example 3) was E. coli BL21 was inoculated into 50 mL LB liquid medium and cultured at 37 ºC and 180 rpm for 18 h. The bacterial solution was transferred to 300 mL LB liquid medium at a 1% inoculum volume and continued to be cultured at 37 ºC with shaking until the bacterial OD reached 0. 600 Between 1.0 and 1.2. Add 30 µL IPTG (0.5 mol / L) to the bacterial solution and culture at 16 ºC and 180 rpm for 24 h.
[0052] Purification and analysis of mutant β-agarase by affinity chromatography: Purify the protein by affinity chromatography according to the instruction manual of Ni Sepharose 6 FastFlow from GE Company. Add glycerol to the purified sample to 20%, mix well, and store at -20 ℃. Determine the protein concentration by Bradford method. Take an appropriate amount of sample for SDS-PAGE electrophoresis analysis. The results are as follows: Figure 2 As shown. In the figure, M: Marker; 1: WT (β-agarase Y3R1); 2: K82L; 3: K82P; 4: S277P; 5: A34F; 6: A34Y; 7: A34W; 8: S294G. β-Purified WT and mutants showed a single band on SDS-PAGE with the same molecular weight of 34.1 kDa.
[0053] Example 5 Study on the enzymatic properties of mutant β-agarase Activity determination of β-agarase: The activity of β-agarase was determined using the 3,5-dinitrosalicylic acid method (DNS method). Take 5 µL of enzyme solution (enzyme content is 200 ng) and add 495 µL of 5 mg / mL agarose substrate solution (dissolved in 50 mmol / L sodium phosphate buffer, pH 7.0). After incubation at 60°C for 15 min, add 500 µL of DNS colorimetric agent, boil for 10 min, and use a microplate reader to measure the absorbance at 540 nm. The activity unit of agarase is defined as: under certain conditions, the amount of enzyme required to generate 1 µmoL galactose per minute is one enzyme activity unit (U). The experiment was repeated three times and the average value was taken. Figure 3 As shown, compared with Y3R1 (WT), all single-point mutants had enzymatic activity, among which the enzyme activities of K82L and A34Y were significantly reduced, the activities of mutants A34F, K82P and A34W did not change significantly, and the mutations of S277P and S294G increased the enzyme activity by 59.5% and 21.6%, respectively, which indicated that the mutations of amino acid at position 277 and amino acid at position 294 were beneficial and had a positive effect on the enzyme activity.
[0054] Analysis of enzyme thermal stability: β-agarase (enzyme content 400 ng) was incubated at different temperatures of 40-80°C for 60 min, placed on ice for 5 min, and then 5 mg / mL agarose substrate (dissolved in 50 mmol / L sodium phosphate buffer, pH 7.0) was added for 15 min. The residual activity of β-agarase was determined with the enzyme activity without heat treatment as 100% to study its thermal stability. Figure 4 As shown in the figure, Y3R1 retained 48.42% and 9.41% residual activity after treatment at 60℃ and 80℃, respectively. The thermal stability of five of the seven mutants (S294G, S277P, K82P, K82L and A34W) was improved to varying degrees. Among them, the thermal stability of S294G and S277P was significantly improved. After incubation at 80℃ for 1h, S294G and S277P still had 79.5% and 76.7% residual activity, respectively, which was 70.1% and 67.0% higher than that of Y3R1, respectively.
[0055] Determination of the optimal reaction temperature of the enzyme: Using 5 mg / mL agarose solution (dissolved in 50 mmol / L sodium phosphate buffer, pH 7.0) as the substrate, the catalytic activity of β-agarase (enzyme content of 200 ng) at different temperatures (50-75°C) was studied, and its optimal temperature was explored with the highest enzyme activity as 100%.
[0056] Determination of the optimal reaction pH of the enzyme: The catalytic activity of β-agarase (enzyme content 200 ng) on agarose substrate in different pH buffers (pH 3.0-11.0) was determined at 60°C. The optimal reaction pH of the enzyme was studied with the highest enzyme activity as 100%. The buffers used were 50 mmol / L citric acid-Na2HPO4 buffer (pH 3.0-5.0), sodium phosphate buffer (pH5.0-9.0), and Gly-NaOH buffer (pH 9.0-11.0).
[0057] Determination of enzyme kinetic parameters: 0.1%-0.3% agarose substrate solution was incubated with purified β-agarase at 60°C and pH 7.0 for 15 min. The Michaelis constant of β-agarase ( K m ) and the maximum enzyme reaction rate ( V max ).
[0058] The results are shown in Table 12. Except for S277P and A34W, the optimum temperature and optimum pH of the other single-point mutants did not change. The optimum temperature of A34W was reduced to 60°C, while S277P showed a higher optimum reaction temperature of 70°C, which is beneficial for the enzyme to perform enzymatic hydrolysis at high temperature. K The m values decreased, indicating that the substrate binding affinity was improved after mutation. V max were significantly improved, which is conducive to faster degradation of substrates by the enzyme, improving the preparation of new agar oligosaccharides and facilitating their application. By comparing the enzymatic properties, it was found that the enzyme activity and thermal stability of S277P and S294G were significantly improved, so other analyses were performed on these two mutants in the follow-up.
[0059] Table 12 Comparison of enzymatic properties of β-agarase Y3R1 and its single-point mutants
[0060] Example 6 Fluorescence spectral analysis of mutant β-agarase: The fluorescence spectra of Y3R1 and mutant β-agarase (in 50 mmol / L phosphate buffer, pH 8.0) were measured using a fluorescence spectrophotometer. The surface hydrophobicity of β-agarase was determined using the fluorescent probe 8-anilino-1-naphthalenesulfonic acid (ANS). Spectral analysis was performed using a fluorescence spectrophotometer. The excitation wavelength was 317 nm, and the emission spectrum from 330 to 500 nm was recorded. The optical diameter of the sample cell was 1 cm. The measurement temperature was 25°C, the excitation slit width and the emission slit width were both 5 nm, and the processed data were expressed as the average of three measurements. The fluorescence spectra of Y3R1 (WT) and mutants S277P and S294G showed the same maximum fluorescence emission at 392 nm ( Figure 5 A), indicating that the mutation has no significant effect on the tertiary structure of β-agarase. Surface hydrophobicity analysis of Y3R1 and mutants showed that compared with WT, mutants S277P and S294G showed weaker fluorescence intensity after binding to ANS ( Figure 5 B).
[0061] Molecular docking of mutant β-agarase and neoagarotetrose: Molecular docking of β-agarase and neoagarotetrose was achieved using AutoDock Vina 1.2.0. β-agarase and neoagarotetrose were pre-processed using AutoDock Tools software, and the files were saved in .pdbqt format. The docking center and box size of the docking box were adjusted using AutoDock Tools, and the enzyme and substrate molecules were docked using AutoDock Vina, and the docking result with the lowest overall energy and the best structure was selected. Discovery Studio 2019 and LigPlot were used to analyze the docking results. + The program analyzes protein-ligand interactions in two-dimensional graphs. Figure 6 and Figure 7 As shown, the binding energies of S277P and S294G with neoagarotetrose are -8.80 kcal / mol and -8.92 kcal / mol, respectively. Compared with the binding energy of Y3R1 (WT) with neoagarotetrose -8.51 kcal / mol, the molecular docking energy of the mutant is lower. The lower the energy of the molecular docking conformation, the more stable the binding conformation, reflecting the greater possibility of binding between the receptor molecule and the ligand. Compared with Y3R1, the mutant S277P has one more hydrogen bond and one Pi-Sigma bond ( Figure 6 B); Two hydrogen bonds and one Pi-Sigma bond were added between the mutant S294G and the ligand ( Figure 7B). The binding between mutants S277P and S294G and neoagarotetrose is stronger than that between WT and neoagarotetrose, which is conducive to the catalytic reaction. The hydrophobic interactions between protein and neoagarotetrose were analyzed by Ligplot+ software. Trp55, Phe163, Glu135, Glu130 and Phe158 residues were found to form hydrophobic interactions with neoagarotetrose in WT, S277P and S294G. Ten hydrophobic interactions were formed between WT and neoagarotetrose, while S277P and S294G increased 2 and 1 hydrophobic interactions with neoagarotetrose, respectively. In the hydrophobic pocket of the enzyme active site, the increase in hydrophobic interactions will limit the movement of neoagarotetrose, making it easier to contact with the catalytic residues (Glu135 and Glu130), thereby improving the catalytic efficiency.
[0062] Molecular dynamics simulation of mutant β-agarase: Molecular dynamics simulation of β-agarase was performed using Gromacs 2022.3 software. The reference temperature of the simulation was set to 333 K and 338 K, the pressure was set to atmospheric pressure (1 Bar), the force field used was GROMOS96 54a7 force field, the solvent was water molecules (SPC water model) and by adding an appropriate amount of Na + ions to neutralize the total charge of the simulation system. The simulation system first uses the steepest descent method to minimize the energy, and then performs 100,000 steps of isothermal isochoric ensemble (NVT) equilibrium and isothermal isobaric ensemble (NPT) equilibrium, with a coupling constant of 0.1 ps and a duration of 100 ps. Finally, a free molecular dynamics simulation is run, which consists of 5,000,000 steps with a step length of 2 fs and a total duration of 100 ns. After the simulation is completed, the software's built-in tools are used to analyze the trajectory, and the root mean square deviation (RMSD), root mean square fluctuation (RMSF), gyration radius (Rg), free energy profile and other data of the motion trajectory of each amino acid are calculated. The results are shown in the figure. Figure 8 As shown in the figure, the overall change trend of the gyration radius of mutants S277P and S294G is relatively low, and their overall average Rg values are 1.97 and 1.94 nm, respectively, which are both smaller than the overall average Rg value of WT, 2.06 nm. The smaller the gyration radius, the tighter the system is bound, and the larger the Rg, the looser the structure. This shows that under the environment of 338 K, the structural compactness of the mutant is improved and the structural stability is stronger. At 338 K, the average RMSD values of Y3R1, S277P and S294G are 0.33nm, 0.16nm and 0.21nm, respectively ( Fig. 9). The average RMSD values of S277P and S294G are smaller than those of WT, indicating that the mutants S277P and S294G have smaller structural deviations at 338K and more stable conformations. 90% of the amino acid residues in S277P have enhanced flexibility. The flexibility and substrate binding of enzymes are important factors affecting the catalytic efficiency of enzymes. The enhancement of amino acid flexibility is conducive to the opening of its catalytic channel, allowing the substrate to enter and exit more freely and to contact the catalytic triad more easily, thereby improving the catalytic efficiency of the enzyme ( Fig.10 A). S294G showed stronger rigidity in the regions of amino acids Ser277-Gly284 (located in the random coil) and Ser300–Gln313 (located in α6 and β21), indicating that the change of amino acid 294 reduced the RMSF of the R1 domain, enhanced the rigidity of the R1 domain, reduced the translational movement of the side chain, and thus increased the stability of the protein ( Fig.10 B). Solvent-accessible surface area (SASA) is the surface area of biological molecules accessible to solvents and is used to evaluate the degree of surface exposure of protein molecules. During the kinetic simulation, the SASA of mutants and WT were calculated. The results showed that the SASA values of WT, S277P and S294G were 156.72, 148.63 and 149.17 nm / S2 / N, respectively. Fig.11 The SASA change trends of the proteins are similar, but the SASA values of S277P and S294G are smaller overall, indicating that the surface exposure of the protein is smaller after mutation and the structure is more stable.
[0063] Preparation of mutant β-agarase hydrolyzate: Take 15 mL, 0.5% (w / v) agar substrate solution (dissolved in 50mmol / L sodium phosphate buffer, pH 7.0), add 15 U purified agarase, and react in a constant temperature water bath at 60°C. Shake well every 15 minutes to allow full enzymolysis, and measure the reducing sugar content of the system until the reducing sugar content remains constant. After heating at 100°C for 10 minutes to terminate the reaction, add 3 times the volume of anhydrous ethanol and let it stand at 4°C overnight. Remove the undegraded agar in the system by suction filtration, remove anhydrous ethanol and excess water by rotary evaporator, and then freeze-dry to obtain the enzymolysis product.
[0064] LC-MS analysis of the enzymatic hydrolysis products of mutant β-agarase: The enzymatic hydrolysis products were analyzed by liquid chromatography-mass spectrometry (LC-MS). The liquid phase model was Waters I-Class, the mass spectrometer model was Waters XEVO-TQS micro, and the chromatographic column model was ACQUITY UPLCr BEH C18 1.7 μm (column length 100 mm). The separation conditions were: column temperature: 35°C; flow rate: 0.3mL / min; injection volume: 1 μL; mobile phase: 0.05% ammonia solution / acetonitrile. Mutants S277G and S294G both showed absorption peaks at 0.57min and 0.75min, and mass spectrometry results showed that the enzymatic hydrolysis products were neoagarbiose, tetrasaccharide and hexasaccharide ( Fig.12 and Fig.13 The degradation products of the mutants were the same as those of β-agarase Y3R1, indicating that the mutation did not change the degradation mode of the enzyme.
[0065] In summary, according to an embodiment of the present invention, the amino acid sequence of Y3R1 was screened by multiple factors through multiple servers, 7 single-point mutants were constructed, and their enzymatic properties were analyzed. The results showed that the thermal stability of 5 of the 7 mutants increased to varying degrees. Among them, single-point mutants S277P and S294G with significantly improved enzyme activity and thermal stability were screened out. Compared with Y3R1, the enzyme activities of S277P and S294G increased by 59.5% and 21.6%, and the thermal stability of S277P and S294G at 80°C increased by 67% and 70%, respectively. Through molecular docking, additional hydrogen bonds, Pi-Sigma bonds and hydrophobic interactions are generated between the protein and the new agar tetraose, which may be an important reason for the increase in enzyme activity. Through surface hydrophobicity analysis and kinetic simulation analysis, it is shown that the improvement of mutant thermal stability is related to the reduction of protein surface hydrophobicity, enhanced structural compactness, and a reduction in solvent accessible surface area.
[0066] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms should not be understood as necessarily being directed to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine different embodiments or examples described in this specification.
[0067] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations of the present invention. A person skilled in the art may change, modify, replace and vary the above embodiments within the scope of the present invention.
Claims
1. A β-agarase mutant with improved thermal stability, It is characterized in that The mutant is obtained by mutation of the amino acid sequence of β-agarase Y3R1 shown in SEQ ID NO: 1, and the mutation site is S277P or S294G.
2. The β-agarase mutant according to claim 1, It is characterized in that The amino acid sequence of the mutant is shown as SEQ ID NO: 2 or SEQ ID NO:
3.
3. A gene encoding the β-agarase mutant according to claim 1 or 2.
4. A construct, It is characterized in that Comprising the gene as claimed in claim 3.
5. A recombinant cell expressing the β-agarase mutant according to claim 1, or containing the gene according to claim 3, or containing the construct according to claim 4.
6. A method for constructing a β-agarase mutant as claimed in claim 1 or 2, It is characterized in that The following steps are involved: (1) Using four online softwares, namely kinetic simulation, PoPMuSiC, HoTMuSiC and I-Mutant 2.0, we predicted mutants with improved thermal stability. The screening conditions were set as ΔΔG<–0.3, RMSF≥0.4, DDG<0 and ΔTm>0.5, and seven single-point mutation sites were screened out. (2) designing site-directed mutagenesis primers, and performing site-directed mutagenesis on the gene of β-agarase Y3R1 whose amino acid sequence is shown in SEQ ID NO: 1 by PCR to obtain a recombinant vector containing the gene sequence of the β-agarase mutant; (3) Transform the mutated recombinant vector into Escherichia coli E. coli In BL21(DE3), induced expression and purification were performed to obtain 7 single-point mutation β-agarase mutants; (4) The enzymatic properties of seven single-point mutation β-agarase mutants were analyzed, and the β-agarase mutants S277P and S294G with co-evolved enzyme activity and thermal stability were screened out.
7. The method for constructing a β-agarase mutant according to claim 6, It is characterized in that The sites of the seven single-point mutations are K82L, K82P, S277P, A34F, A34Y, A34W, and S294G.
8. The method for constructing a β-agarase mutant according to claim 7, It is characterized in that The amplification primer sequences for the mutation site K82L are SEQ ID NO: 6 and SEQ ID NO: 7; The amplification primer sequences for the mutation site K82P are SEQ ID NO: 8 and SEQ ID NO: 9; The amplification primer sequences for the mutation site S277P are SEQ ID NO: 10 and SEQ ID NO: 11; The amplification primer sequences for mutation site A34F are SEQ ID NO: 12 and SEQ ID NO: 13; The amplification primer sequences for mutation site A34Y are SEQ ID NO: 14 and SEQ ID NO: 15; The amplification primer sequences for mutation site A34W are SEQ ID NO: 16 and SEQ ID NO: 17; The sequences of primers for amplifying the mutation site S294G are SEQ ID NO: 18 and SEQ ID NO:
19.
9. Use of the β-agarase mutant according to claim 1, or the encoding gene according to claim 3, or the construct according to claim 4, or the recombinant cell according to claim 5 in degrading agar or preparing agar-oligosaccharides.
